These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33452912)

  • 1. The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhang K; Guo RQ; Chen SW; Chen B; Xue XB; Chen S; Huang J; Liu M; Tian Y; Zuo L; Chen M; Zhou LQ
    World J Urol; 2021 Sep; 39(9):3489-3495. PubMed ID: 33452912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
    Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Zhang K; Liu Y; Yang W; Wang J; Yang J; Zhang G; Bai W; Chen S
    Urology; 2021 Jul; 153():264-269. PubMed ID: 33482135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
    Morgia G; Russo GI; Urzì D; Privitera S; Castelli T; Favilla V; Cimino S
    Arch Ital Urol Androl; 2017 Jun; 89(2):110-113. PubMed ID: 28679180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
    Giammusso B; Di Mauro R; Bernardini R
    Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
    Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
    Nickel JC; Downey J; Clark J; Casey RW; Pommerville PJ; Barkin J; Steinhoff G; Brock G; Patrick AB; Flax S; Goldfarb B; Palmer BW; Zadra J
    Urology; 2003 Oct; 62(4):614-7. PubMed ID: 14550427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Finnish version of The National Institutes Of Health Chronic Prostatitis Symptom Index correlates well with the visual pain scale: translation and results of a modified linguistic validation study.
    Leskinen MJ; Mehik A; Sarpola A; Tammela TL; Järvelin MR
    BJU Int; 2003 Aug; 92(3):251-6. PubMed ID: 12887478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Electroacupuncture with Different Waveforms on Chronic Prostatitis/Chronic Pelvic Pain Syndromes: A Randomized Controlled Trial.
    Li Z; Liu J; Liu P; Zhang Y; Han W
    Contrast Media Mol Imaging; 2022; 2022():6866000. PubMed ID: 35935300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
    Pontari MA; Krieger JN; Litwin MS; White PC; Anderson RU; McNaughton-Collins M; Nickel JC; Shoskes DA; Alexander RB; O'Leary M; Zeitlin S; Chuai S; Landis JR; Cen L; Propert KJ; Kusek JW; Nyberg LM; Schaeffer AJ;
    Arch Intern Med; 2010 Sep; 170(17):1586-93. PubMed ID: 20876412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of a Combination of Vaccinium Macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the Prevention of Chronic Bacterial Prostatitis: A Double-Blind Randomized Study.
    Chiancone F; Carrino M; Meccariello C; Pucci L; Fedelini M; Fedelini P
    Urol Int; 2019; 103(4):423-426. PubMed ID: 31527377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: An Italian prospective multicenter study.
    Presicce F; Barrese F; Cantiani A; Filianoti A; Tuzzolo D; Di Palma P; Lauretti S; Brunori S; Martini M
    Asian J Urol; 2022 Apr; 9(2):139-145. PubMed ID: 35509480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
    Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
    Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.